Target intelligence / Profile preview

G protein beta-gamma subunit complex (Gβγ complex)

Target
Gβγ complex
Molecular classification
G protein subunit
01

Overview

The G protein beta-gamma subunit complex (Gβγ) is a tightly bound dimeric component of heterotrimeric G proteins associated with G protein-coupled receptors (GPCRs). In its inactive state, Gβγ binds Gα-GDP to maintain the heterotrimer and enhance Gα affinity for GDP; upon GPCR activation, GTP exchange on Gα leads to dissociation, freeing Gβγ to act as a signaling molecule that regulates diverse effectors including ion channels (e.g., activating GIRK channels, inhibiting voltage-gated calcium channels), enzymes like phospholipase Cβ and adenylyl cyclase, and kinases such as GRK2 for receptor desensitization.[1][2][3] There are five mammalian Gβ subtypes (β-propeller structures with WD repeats) and eleven Gγ subtypes (prenylated for membrane targeting), allowing combinatorial specificity in signaling.[2] Gβγ plays key roles in heart function by recruiting GRK2 to desensitize β-adrenergic receptors, contributing to heart failure pathology; inhibiting this interaction with agents like GRK2ct improves cardiac contractility in models.[2] In inflammation, Gβγ activates PI3Kγ downstream of chemokine GPCRs to promote neutrophil recruitment.[2] It also drives leukemia via RhoGEF activation and chemotaxis.[2] As a therapeutic target, Gβγ modulation offers potential in cardiovascular disease, inflammation, and cancer, though challenges include preserving Gα signaling and avoiding broad GPCR disruption.[1][2]

Other names
G beta-gamma complexGβγ subunitsG beta gamma subunitsGβγ dimer
02

Mechanism of action

Inhibition of Gβγ-GRK2 interaction to prevent receptor desensitization; Blocking Gβγ signaling to effectors like PI3Kγ or RhoGEF; Prenylation inhibition of Gγ subunit

03

Biological functions

Signal transductionReceptor desensitizationIon channel regulationEnzyme activation/inhibition
04

Disease associations

Cardiovascular diseaseInflammationLeukemiaHeart failure
05

Safety considerations

Potential interference with heterotrimeric G protein formation or Gα signalingDisruption of essential GPCR signaling pathways
06

Interacting drugs

GRK2ct (peptide inhibitor)

1 more in the full profile.

Beyond the preview

Go deeper on G protein beta-gamma subunit complex (Gβγ complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein beta-gamma subunit complex (Gβγ complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call